HilleVax (NASDAQ:HLVX) Issues Quarterly Earnings Results

HilleVax (NASDAQ:HLVX) released its quarterly earnings data on Friday. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.33) by ($0.02), Zacks reports.

HilleVax Trading Down 1.2 %

Shares of NASDAQ:HLVX traded down $0.02 during mid-day trading on Friday, reaching $1.59. The company had a trading volume of 97,820 shares, compared to its average volume of 430,237. The company’s 50-day moving average price is $1.82 and its 200-day moving average price is $1.86. HilleVax has a one year low of $1.55 and a one year high of $16.66. The firm has a market cap of $79.19 million, a price-to-earnings ratio of -0.51 and a beta of 0.76.

HilleVax Company Profile

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.